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Abstract
The cytotoxicity and free radical production induced by vanadium compounds were investigated in an osteoblast
(MC3T3E1) and an osteosarcoma (UMR106) cell lines in culture. Vanadate induced cell toxicity, reactive oxygen
species (ROS) formation and thiobarbituric acid reactive substances (TBARS) increased in a concentration-dependent
manner (0.1–10 mM) after 4 h. The concentration–response curve of vanadate-induced cytotoxicity and oxidative
stress in MC3T3E1 cells was shifted to the left of the UMR106 curve, suggesting a greater sensitivity of the
non-transformed cells in comparison to the osteosarcoma UMR106 cells. Supplementing with vitamin E acetate (80
mM) significantly inhibited ROS and TBARS formation but did not improve the vanadate-dependent decrease in cell
number. Other vanadium compounds (vanadyl, pervanadate, and VO/Aspi, a complex of vanadyl(IV) with aspirin)
showed different degrees of cell toxicity and induced oxidative stress. Altogether these results suggest that oxidative
stress is involved in vanadium induced osteoblastic cytotoxicity, although the mechanism is unknown. © 2000
Elsevier Science Ireland Ltd. All rights reserved.
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1. Introduction
Vanadium is a trace element that is widely
distributed in the earth. Although vanadium is
known to be essential for a number of species, its
role as a micronutrient in humans has yet to be
established. The main source of vanadium in the
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general population is food and atmospheric vana-
dium, although their contribution varies between
industrial or rural areas (Nriagu, 1998). Vanadi-
um(V) enters the organism by inhalation, the
gastrointestinal tract and the skin. Once absorbed,
vanadate is reduced to vanadyl(IV) by the glu-
tathione of erythrocytes or by ascorbic acid and
other reducing substances in plasma and is trans-
ported by albumin and transferrin (Degani et al.,
1981). Vanadium is specially stored in certain
organs, mainly in bone, kidney and liver (Etchev-
erry and Cortizo, 1998).
On the other hand, there are now increasing
evidence that vanadium can also be toxic to living
systems (Domingo, 1996; Sabbioni et al., 1993).
An excess of vanadate induces toxic effects in
workers of industrial populations possible by oxi-
dative stress (Halliwell and Gutteridge, 1999). As
a phosphate analogue, vanadate and its deriva-
tives interfere with a number of enzymes of phos-
phate metabolism. For instance, it inhibits
different ATPases. Vanadate inhibits protein ty-
rosine phosphatases and therefore resulting in ac-
cumulation of phosphorylated protein tyrosine
residues in several cells (Gresser and Tracey,
1990). In addition, these properties point the po-
tential capacity of vanadium in the regulation of
different physiological processes such as cell
growth, differentiation, glucose and lipid
metabolism (Stern et al., 1993). Experimental evi-
dence thus suggests that vanadium has insulin-
and growth factor-like properties. On the other
hand, it has been shown beneficial effects of vana-
dium compounds in the treatment of experimental
diabetic rats (Shechter, 1990) and recently in clin-
ical trials in diabetic patients (Goldfine et al.,
1995; Cohen et al., 1995; Halberstam et al., 1996;
Cusi et al., 1997). These facts suggest that vana-
dium compounds could be potential pharmaceuti-
cal tools to ameliorate certain diseases. To
understand the insulin-like properties and the tox-
icity of vanadium compounds it will be essential
to know the mechanism of action as well as the
susceptibility of different cells and tissues to the
effects of vanadium.
It was shown early that vanadate induces lipid
peroxidation in isolated hepatocytes as well as in
the perfused rat liver (Stacey and Klaassen, 1981;
Younes and Strubelt, 1991a). The role of oxida-
tive mechanisms in vanadate-induced hepatotoxic-
ity was suggested by the use of antioxidant agents
(Younes et al., 1991b). Recently, Krejsa et al.
(1997) has suggested a role for oxidative stress in
the action of vanadium on the lymphocyte signal
transduction pathway. These authors have shown
that redox-dependent effects occur in concert with
redox-independent actions.
Using a model of murine osteoblast-like cells in
culture, we have previously shown that vanadium
compounds exert a biphasic effect on cell growth:
low micromolar concentrations stimulated cell
proliferation while high concentrations inhibit cell
proliferation (Cortizo and Etcheverry, 1995;
Etcheverry et al., 1997; Barrio et al., 1997; Sa´lice
et al., 1999). In addition, we have observed that
UMR106, an osteosarcoma cell line, was less af-
fected by high levels of vanadium (Cortizo and
Etcheverry, 1995), while non-transformed
MC3T3E1 mouse calvaria osteoblastic cells were
very sensitive to the growth inhibitory effects of
this element (Sa´lice et al., 1999). Moreover, the
MC3T3E1 line showed morphological alterations
after the incubation with vanadium derivatives
(Etcheverry et al., 1997; Sa´lice et al., 1999).
The aim of the present study was to investigate
if oxidative mechanisms are involved in the cyto-
toxic effects induced by vanadium compounds in
osteoblast-like cells. For this purpose, we deter-
mined: (1) osteoblastic vanadium-induced cyto-
toxicity by the crystal violet bioassay, a
determination that evaluates cell survival; (2) lipid
peroxidation estimated by thiobarbituric acid re-
active substances (TBARS) and the formation of
reactive oxygen species (ROS) using the probe
dihydrorhodamine123 (DHR); and (3) possible
prevention of cytotoxic and oxidative stress by the
preincubation with vitamin E.
2. Materials and methods
2.1. Materials
Vanadium (IV) oxide sulfate (vanadyl sulfate)
was obtained from Merck (Darmstadt, Germany).
Sodium orthovanadate (V), 2-thiobarbituric acid,
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1,1,3,3-tetramethoxypropane, and rhodamine123
were purchased from Sigma Chemical Co. (St.
Louis, MO). Dihydrorhodamine123 (DHR) was
from Molecular Probes, (Eugene, OR). Vitamin E
was a gift from RP Scherer Argentina S.A.I.C
(Buenos Aires, Argentina). Tissue culture material
was provided by Corning (Princeton, NJ). Dul-
becco’s Modified Eagles Medium (DMEM) and
trypsin-EDTA were supplied by Gibco (Gaithers-
burg, MD) and fetal bovine serum (FBS) from
Gen (Buenos Aires, Argentina). All other chemi-
cals used were of analytical grade from Sigma.
2.2. Solutions
Fresh stock solutions of vanadyl (IV) sulfate
(VO) and sodium o-vanadate (V) were prepared
in distilled water at a 100 mM concentration and
diluted according to the concentrations indicated
in the legends of the figures (Cortizo and Etchev-
erry, 1995). Peroxovanadate (perV) was prepared
according to Trudel et al. (1991) where stock
solutions containing 1 mM orthovanadate and 2
mM H2O2 were incubated for 15 min at room
temperature and then treated with catalase (200
mg/ml) for 3 min before immediate use in experi-
ments, after appropriate dilutions. A complex of
vanadyl with aspirin (VO/Aspi) was synthesized
and characterized as we have described (Etchev-
erry et al., 1999).
2.3. Fluorescent probes
DHR was prepared as a 25 mM and rho-
damine123 as a 0.5 mM stock solutions in nitro-
gen-purged dimethylformamide and stored in the
dark at −20°C until used (Royall and Ischiro-
poulos, 1993). A 10 mM stock solution of DHR
was prepared fresh each day in Hanks’ balanced
salt solution (HBSS). A standard curve of rho-
damine123 was constructed from 0.1 to 5 mM.
2.4. Cell culture and incubations
MC3T3E1 osteoblastic mouse calvaria-derived
cells and UMR106 rat osteosarcoma-derived cells
were grown in 75 cm2 flasks at 37°C in a humi-
dified 5% CO2 atmosphere in DMEM supple-
mented with 100 U/ml penicillin, 100 mg/ml
streptomycin and 10% (v/v) FBS. When 70–80%
confluence was reached, cells were subcultured
using 0.1% trypsin-1 mM EDTA in Ca2+ –Mg2+
free phosphate buffered saline PBS (Cortizo and
Etcheverry, 1995; Etcheverry et al., 1997). For
experiments, cells were seeded in six- or 24-well
plates at a density of 2.5×104 cells/well. When
cells reached confluence, the monolayers were
washed with HBSS and incubated as describe
below. The effect of the antioxidant was tested by
incubating cells with 80 mM vitamin E in DMEM
without FBS for 24 h at 37°C. At this concentra-
tion of vitamin E, a maximal inhibition of
TBARS formation was obtained without toxic
effects. Control cells were preincubated in the
absence of the vitamin supplement but in the
presence of vehicle (0.1% ethanol).
2.5. Cell sur6i6al. Crystal 6iolet bioassay
The viability of osteoblast-like cells was deter-
mined by the crystal violet bioassay (Okajima et
al., 1992). Briefly, cells were washed with PBS and
fixed with 5% glutaraldehyde for 10 min. The
cultures were then stained with 0.5% crystal violet
in 25% methanol for 10 min. Therefore, the excess
dye was discarded and the plates were washed
with water and dried. The dye taken up by the
cells was extracted using 0.1 M glycine/HCl
buffer, pH 3.0/30% methanol and transferred to
test tube. Absorbance was read at 540 nm after a
suitable dilution. We have previously shown that
under these conditions, the colorimetric bioassay
strongly correlated with viable cell number mea-
sured by cell counting in a Neubauer chamber
(r=0.90, PB0.001; r=0.97, PB0.001; for
UMR and MC3T3E1 cells, respectively) (Cortizo
and Etcheverry, 1995; Sa´lice et al., 1999).
2.6. Determination of ROS formation
Intracellular ROS generation in osteoblast-like
cells was measured by oxidation of DHR to rho-
damine. This probe measures levels of ROS inter-
mediates peroxynitrite and the hydroxyl radical
OH but not O2
− or H2O2 (Royall and Ischiro-
poulos, 1993). Briefly, osteoblast-like cells were
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incubated at 37°C in 1.5 ml HBSS alone (basal
condition) or with several vanadium compounds,
in the presence of 10 mM DHR (Krejsa et al.,
1997). Media were separated and the cell mono-
layers rinsed with PBS and scraped into 1 ml 0.1%
Triton-X100. The cell extracts were then analyzed
for the oxidized product rhodamine by measuring
fluorescence (excitation wavelengh, 495 nm; emis-
sion wavelengh, 532 nm), using an Aminco-Bow-
man SPF100 spectrofluorometer equipped with a
Hamamatsu R928 photomultiplier tube. Results
were corrected for protein content, which was
assessed by the method of Bradford (1976).
2.7. TBARS production
Cells were incubated in 1.5 ml HBSS without
(basal condition) or with several vanadium com-
pounds at 37°C for different incubation periods.
Media were separated, cells washed with PBS and
scraped in 200 ml 0.1% Triton-X100. An aliquot
was saved for protein determination. To measure
the extent of lipid peroxidation, the TBARS assay
was carried out as reported by Ohkawa et al.
(1979). Each cell extract was mixed with 1 ml 20%
acetic acid pH 3.5 and 1 ml 0.78% aqueous solu-
tion of thiobarbituric acid. After heating at 95°C
for 1 h, the mixtures were centrifuged at 3000 rpm
for 15 min and the red pigment in the supperna-
tant fractions were estimated by absorbance at
532 nm. The lipid peroxide levels were expressed
in terms of nmol of malondialdehyde per mg
protein, using 1,1,3,3-tetramethoxypropane as
standard.
2.8. Statistical analysis
At least three experiments were performed for
each experimental condition. Results are ex-
pressed as mean 9S.E.M. Statistical differences
were analyzed using Student’s t-test. Correlation
among different parameters was analyzed using
Pearson’s correlation coefficient as well as the
linear regression method.
3. Results
3.1. Vanadate induces cytotoxicity in
osteoblast-like cells
The cytotoxicity induced by vanadate was esti-
mated measuring cell survival in two lines of
murine osteoblast-like cells by the crystal violet
bioassay. Fig. 1A shows that in the presence of
low concentrations of vanadate (0.1–0.5 mM) cell
survival was preserved in the UMR106 cells. Nev-
Fig. 1. Cell survival of osteoblast-like cells after a 4-h incuba-
tion with vanadate (A) or 1 mM of various vanadium com-
pounds (B). Values are expressed as % basal survival and
represent the means 9S.E.M., n=6. Statistically significant
differences between the effect of each compound in both cell
lines: c PB0.05, * PB0.01, ** PB0.001.
A.M. Cortizo et al. / Toxicology 147 (2000) 89–99 93
ertheless, increasing the concentration of vanadate
up to 10 mM caused a concentration-dependent
decrease in cell survival, which was statistically
significant after 1 mM. In the MC3T3E1 cells,
vanadate caused a greater cytotoxic effect, signifi-
cantly decreasing cell number at 0.1 mM, with a
concentration–response curve to left of the
UMR106 cell curve. This observation suggests a
greater sensitivity to vanadate cytotoxicity for the
non-transformed line. In order to evaluate further
this differential effect, other vanadium com-
pounds were tested for their ability to induce loss
of viable cells (Fig. 1B). After a 4 h incubation of
UMR106 cells with 1 mM of different vanadium
compounds, perV and VO/Aspi were compara-
tively more toxic than vanadate, while VO did not
affect cell survival. In the non-transformed
MC3T3E1 cell line, perV was also the more toxic
compound, followed by VO/Aspi. Vanadate and
vanadyl exerted a comparable effect on these cells.
No toxic effect was observed after incubation with
1 mM H2O2 or aspirin in MC3T3E1 or UMR106
cells (data not shown). Altogether, these results
show a similar trend in the potency of the four
vanadium derivatives tested in both cell lines
(perVVO/Aspi\Vi]VO), but with a greater
toxic effect for most of the compounds in the
MC3T3E1 cells.
3.2. Detection of intracellular ROS
Osteoblast-like cells were loaded for 4 h with
DHR and the oxidized content of the fluoresecent
product rhodamine was assessed. The basal con-
tent of rhodamine produced was four-fold higher
than in the non-transformed osteoblastic line. Fig.
2A shows that vanadate caused an incremental
increase in the ROS formation after 4 h of incu-
bation in both cell lines, with a threshold of 0.1
mM (PB0.001) and a saturation at approxi-
mately 2.5 mM. Furthermore, the UMR106 os-
teosarcoma line is more resistant than MC3T3E1
cells to the vanadate-induced free radical forma-
tion. In experiments with UMR106 cells, the
dose–response curve was displaced to the right of
the MC3T3E1 curve, suggesting lower sensitivity.
The ROS production was also time-dependent
(Fig. 2B), reaching a maximum after 3–4 h of
incubation and detected as early as 30 min, in the
presence of 2.5 mM vanadate.
Inductional ROS formation was also evaluated
using other vanadium derivatives (Fig. 2C). The
complex with aspirin generated minor although
significant free radicals in both cell lines. Pervana-
date was equivalent to VO/Aspi in the osteosar-
coma cells but as potent as VO in the
non-transformed MC3T3E1 line. For most of the
compounds, the MC3T3E1 cells were more sensi-
tive than UMR106 cells.
3.3. TBARS production during 6anadate
cytotoxicity
Lipid peroxidation of vanadate-treated os-
teoblasts as well as untreated (basal) cells was
evaluated after a 4 h incubation. The basal
TBARS production was 4.1-fold higher in un-
treated UMR106 than in MC3T3E1 cultures. The
TBARS increased with the vanadate concentra-
tion in the media in a concentration-dependent
manner (Fig. 3A), reaching a maximum at 5 mM.
At low concentrations (0.25 and 0.5 mM) a higher
sensitivity of the MC3T3E1 cells toward the vana-
dium-induced TBARS formation was observed.
The time-dependent increase in 2.5 mM vanadate-
induced TBARS production in MC3T3E1 cells is
shown in Fig. 3B, and can be seen to have
reached a maximum after 3–4 h of incubation, in
parallel to the kinetics of ROS generation (Fig.
2B).
Different vanadium compounds were evaluated
at 1 mM concentrations (Fig. 3C). In these exper-
iments, VO and VO/Aspi were the more potent
TBARS-inductors in both cell lines. Moreover,
the only significant difference between the two
lines was observed in the case of VO/Aspi.
3.4. Effect of 6itamin E on 6anadate toxicity
The cytotoxicity and oxidative stress induced
by vanadate on MC3T3E1 osteoblast-like cells
were further evaluated after 24 h of 80 mM vita-
min E supplementation in the culture media. This
concentration was previously shown to do not
induce toxicity in the MC3T3E1 cells (data not
shown).
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Fig. 2. Effect of vanadate on DHR oxidation to rhodamine. Osteoblast-like cells were incubated with: (A) 10 mM DHR and different
concentrations of vanadate for 4 h; (B) presence of 2.5 mM vanadate for several incubation periods (MC3T3E1); or (C) 1 mM of
different vanadium compounds for 4 h. The generation of ROS was evaluated as described in Section 2. Values represent the means
9S.E.M., n=8. Statistically significant differences between vanadium-induced ROS in both cell lines are: c PB0.05, * PB0.01.
Table 1 shows that no protection was exerted
by vitamin E upon the toxicity of vanadate, as
evaluated by cellular survival. The vanadate-in-
duced DHR oxidation was significantly prevented
by the vitamin E. This antioxidant blunted about
half of the vanadate-induced ROS generation
when 1 or 2.5 mM vanadate was tested.
The osteoblast content of TBARS produced by
similar concentrations of vanadate was also sig-
nificantly inhibited by the preincubation of cells
with vitamin E (Table 1). No effect on lipid
peroxidation was observed when MC3T3E1 cells
were incubated with vitamin E alone, suggesting
no toxicity at the concentration used in this study.
4. Discussion
In this study it was observed that vanadate,
depending on the concentration, causes cytotoxic
effects in osteoblast-like cells. This was evidenced
by the crystal violet bioassay (Fig. 1A). Low
concentrations of vanadate did not show any
effect on cell number. However, high doses of
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vanadate induced loss of cells; the concentration–
response curve of vanadate-induced cytotoxicity
in MC3T3E1 cells was shifted to the left of the
UMR106 curve, suggesting a greater sensitivity of
the non-transformed cells in comparison to the
osteosarcoma UMR106 cells. This observation is
in agreement with our previous results of vana-
date-induced cell growth inhibition in both cell
lines incubated 24 h with low concentrations (25–
100 mM) of different vanadium compounds (Cor-
tizo and Etcheverry, 1995; Sa´lice et al., 1999). In
the present study we evaluated the acute effect of
vanadium on the oxidative stress and cell survival
in the same model of osteoblast-like cells. Previ-
ous studies have shown that vanadate(V) and
vanadyl(IV) can cause oxidative stress through
the formation of TBARS and hydroxyl free radi-
cals in different cell types, incubated for short
periods (Stacey and Klaassen, 1981; Younes and
Strubelt, 1991a; Bay et al., 1997). These effects
were associated with cellular death or membrane
injury. The results obtained in our model system
suggest that the vanadium-induced cytotoxicity is
partially dependent on oxidative stress. This pro-
Fig. 3. Effect of vanadate on lipid peroxidation as evaluated by TBARS production. Cells were incubated with: (A) various vanadate
concentrations for 4 h; (B) 2.5 mM vanadate for different incubation periods (MC3T3E1); or (C) 1 mM of various vanadium
complexes for 4 h. The cellular TBARS were evaluated using a MDA standard. Values represent the means 9S.E.M., n=8.
Statistically significant differences between each compound in both cells lines are: * PB0.01.
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Table 1
Effect of vitamin E on vanadate-induced cytotoxicity, DHR oxidation and TBARS formation in MC3T3E1 osteoblast-like cellsa
Rhodamine123 (nmol/mgVanadate (mM) Cell survival (%Vitamin E (80 TBARS (nmol MDA/mg protein)
basal)mM) protein)
100930 0.03490.007− 5.7090.62
+ 9693 0.04590.011 4.8490.31
6694 0.28090.030*− 13.8091.01*1
+ 6493 0.15090.040* 8.9890.82*
3191 0.33090.040*2.5 15.7090.95*−
2994 0.18090.040*+ 10.5090.76*
a Values given are means 9S.E.M., n=4. Statistically significant differences are obtained in comparison with the basal condition
(without vanadate or vitamin E).
* PB0.05.
posal is supported by the following evidence:
vanadium induced a cytotoxic effect as well as an
oxidative stress in a concentration-dependent
manner (Fig. 1A, Fig. 2A and Fig. 3A). The
oxidative stress caused by vanadium in both os-
teoblast-like cells was evaluated by determining
the rhodamine123 fluorescence and TBARS pro-
duction as parameters related to the generation of
reactive oxygen species. Both parameters were
increased by vanadate in a time-dependent man-
ner, with a maximum effect after 3 h of incuba-
tion.
MC3T3E1 cells were more sensitive than
UMR106 to vanadate cytotoxicity, as well as to
the induction of oxidative stress (TBARS and
ROS) (Fig. 2A and Fig. 3A), suggesting a role for
the pro-oxidative effect of vanadate in its toxicity.
A statistically significant negative correlation was
found between cell survival and the TBARS for-
mation (PB0.02). Furthermore, TBARS mea-
surements showed a positive correlation with
DHR oxidation (PB0.01).
Other investigators have shown lipid peroxida-
tion and cell damage in liver tissue that suggests a
causative role of the pro-oxidant activity of vana-
date in hepatic cytotoxicity (Younes and Strubelt,
1991a). In the osteoblatic cell culture system used
in this study, vanadate induced lipid peroxidation,
as evaluated by TBARS formation. This effect
was time and concentration dependent (Fig. 3A
and B). At low concentrations, MC3T3E1 cells
were more sensitive to vanadate than UMR106
cells. However, higher concentrations (\2.5 mM)
were equally and markedly toxic for both cell
lines. At these concentrations, similar number of
cells survived after 4 h of incubation with vana-
date in both lines (Fig. 1A). All presented evi-
dence in this study is suggestive of a more
deleterious effect of vanadate on cell survival in
the non-transformed MC3T3E1 line, associated
with a higher ROS generation and lipid peroxida-
tion.
The use of different vanadium compounds has
allowed us to further investigate the relationship
between cell toxicity and oxidative stress caused
by vanadium derivatives. We assessed the cyto-
toxic effects of vanadium using different deriva-
tives of vanadium (IV) and (V). Pervanadate was
the most potent inductor of cell toxicity in both
cells lines, while VO was the weaker agent. On the
other hand, VO/Aspi, caused stronger cell toxicity
than Vi in both osteoblastic lines. These results
suggest that the oxidation state of vanadium is
not the only factor that plays a role in the cyto-
toxicity in either MC3T3E1 and UMR106 cells.
For instance, VO/Aspi, a vanadium(IV) com-
pound was more toxic than Vi, a vanadium(V)
derivative. On the other hand, the nature of vana-
dium ligands seems to have an important influ-
ence in this aspect, as can be seen in the case of
the peroxovanadium compound.
The vanadium is an element that exists in sev-
eral oxidation states. In the presence of different
cellular systems it may undergoes redox cycling.
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Through this mechanism O2
− as well as OH, and
lipid peroxides could be generated and conse-
quently, oxidative damage can be promoted. Dif-
ferent vanadium compounds could enter into the
redox cycling with different abilities. In addition,
other factors such as the uptake and compartmen-
tation may determine the different toxicity of
various vanadium compounds.
The ROS formation enhanced by various vana-
dium compounds suggests that this effect, as eval-
uated through DHR oxidation, was dependent on
the species of vanadium and the cellular type (Fig.
2C). For most of the compounds, with the excep-
tion of VO/Aspi complex, MC3T3E1 cells seem to
be more sensitive to oxidative stress than
UMR106 cells. This effect was not completely
dependent on the oxidation state of vanadium
compounds, since vanadyl(IV), pervanadate and
vanadate(V) were equally potent in the non-trans-
formed cell line. On the other hand, VO and
vanadate show stronger effects than VO/Aspi and
perV in the osteosarcoma cell line. Only two
reports have evaluated the free radical production
induced by vanadium compounds using similar
methods to the DHR oxidation. In one of these
studies, treatment of lymphocytes for 2 h with
vanadate, BMOV (a vanadium(IV) complex with
maltol) or pervanadate, differentially induced oxi-
dative stress, pervanadate being the more potent
derivative (Krejsa et al., 1997). In liver cells,
vanadyl(IV) induced oxidative stress via genera-
tion of hydroxyl free radicals (Bay et al., 1997).
Altogether, the experimental evidence seems to
indicate that sensitivity to oxidative stress by
vanadium compounds is dependent on cell type
and geometry requirements.
The level of free radicals inside the cells is a
product of a balance between the generation of
these radicals and the antioxidant defences in the
cells. For instance, the depletion of GSH levels in
the presence of vanadate has been reported in
perfused liver by Younes and Strubelt (1991a). A
similar effect was described in liver cells incubated
with vanadyl(IV) (Bay et al., 1997). Thus, the
depletion of GSH as well as other reducing sub-
stances, or alterations in detoxifying enzymes,
could lead to an increased susceptibility of the
cells to vanadium-induced toxicity.
The comparisons of TBARS formation in both
cell lines incubated with the different vanadium
compounds (Fig. 3C) did not confirm our previ-
ous observation that MC3T3E1 cells are more
sensitive than UMR106 cells to oxidative stress
and cytotoxicity. Although higher TBARS values
were found in the non-transformed cells, the dif-
ferences between the cell lines were not statisti-
cally significant, with the sole exception of
VO/Aspi (PB0.01). This seems to indicate that
lipid peroxidation is not the only factor responsi-
ble for the higher sensitivity of MC3T3E1 cells to
the vanadium-induced toxicity. A different level in
the antioxidant content may explain its sensitivity.
Vitamin E, acting as a potent peroxyl radical
scavenger, inhibits the free radical chain reaction
of lipid peroxidation (Van Acker et al., 1993). The
antioxidant effects of this vitamin have been ex-
tensively described (Mabile et al., 1995; Rego et
al., 1998). The results obtained with this antioxi-
dant suggest that the vitamin only partially, al-
though significantly, inhibits oxidative stress in
osteoblast-like cells incubated with vanadate.
However, the cytotoxicity was not prevented. In
agreement with our results, in a perfused liver
system, other antioxidants, also protected the tis-
sue against lipid peroxidation but only partially
prevented the injury initiated by vanadate
(Younes et al., 1991b). These results suggest that
the vanadium derivative-induced cell toxicity can-
not be simply accounted for their ability to pro-
duce oxidative stress. Furthermore, other factors
could be involved in the lack of effect of vitamin
E to prevent vanadate-induced toxicity. The up-
take, compartmentation and distribution of vita-
min E within the cell may exert significant effects
in relation to cytotoxicity.
In conclusion, vanadium-induced cytotoxocity
is a complex phenomenon depending on several
factors. An increase in oxidative stress is involved
in the toxic effect of vanadium in osteoblastic
cells. In addition, the phenotypic characteristics of
the cells, as well as their mechanisms of defence
and certain geometric features of the vanadium
species, also play a role in vanadium-induced
cytotoxicity.
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